G. V. Koev

Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro

Liangjun Lu, Tanya Dekhtyar, Sherie Masse et al. · Antiviral Research · 2007 · 39 citations

Viral Replication, Molecular Virology, Genetics +6

1206 ABT-072 OR ABT-333 COMBINED WITH PEGYLATED INTERFERON/RIBAVIRIN AFTER 3-DAY MONOTHERAPY IN HCV GENOTYPE 1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS: 12-WEEK SUSTAINED VIROLOGIC RESPONSE (SVR12) AND SAFETY RESULTS

F. Poordad, E. Läwitz, E DeJesus et al. · Journal of Hepatology · 2012 · 21 citations

And Safety Results, Hepatitis C, Viral Hepatitis +9

955 PRECLINICAL POTENCY, PHARMACOKINETIC AND ADME CHARACTERIZATION OF ABT-333, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR

Clarence J. Maring, Renaud Wagner, David Hutchinson et al. · Journal of Hepatology · 2009 · 20 citations

Translational Medicine, Medicine, Immunology +7

867 IN VITRO COMBINATORY EFFECT OF HCV NS3/4A PROTEASE INHIBITOR ABT-450, NS5A INHIBITOR ABT-267, AND NON-NUCLEOSIDE NS5B POLYMERASE INHIBITOR ABT-333

G. V. Koev, Preethi Krishnan, Jill Beyer et al. · Journal of Hepatology · 2012 · 10 citations

Medicine, Immunology, Antiviral Drug Development +6

953 CHARACTERIZATION OF RESISTANCE MUTATIONS SELECTED IN VITRO BY THE NON-NUCLEOSIDE HCV POLYMERASE INHIBITORS ABT-333 AND ABT-072

G. V. Koev, Rubina Mondal, Jill Beyer et al. · Journal of Hepatology · 2009 · 10 citations · Full text

Viral Polymerase Structure, Genetics, Antiviral Drug Development +7